Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Amgen Inc Issues Guidance; Revenue Guidance Above Analysts' Estimates


Wednesday, 23 Jan 2013 04:02pm EST 

Amgen Inc announced that for fiscal 2013, it expects total revenues to be in the range of $17.8 billion to $18.2 billion and adjusted earnings per share (EPS) to be in the range of $6.85-$7.15. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $17.7 billion and EPS of $6.99 for fiscal 2013. 

Company Quote

163.46
2.79 +1.74%
26 Dec 2014